呼吸道合胞病毒（RSV）疫苗的最新进展：述评

Q3 Medicine

Revista Espanola de Geriatria y Gerontologia Pub Date : 2025-02-11 DOI:10.1016/j.regg.2025.101630

José Gutierrez-Rodriguez , Jaime Rodríguez-Salazar , Francisco José Tarazona-Santabalbina

{"title":"呼吸道合胞病毒（RSV）疫苗的最新进展：述评","authors":"José Gutierrez-Rodriguez , Jaime Rodríguez-Salazar , Francisco José Tarazona-Santabalbina","doi":"10.1016/j.regg.2025.101630","DOIUrl":null,"url":null,"abstract":"<div><div>Respiratory syncytial virus (RSV) infections pose a significant challenge to healthcare systems due to their impact on older adults, particularly those who are frail. Implementing an appropriate vaccination policy for these patients could help reduce healthcare resource utilization and costs while enhancing the quality of life for elderly individuals and their families. This narrative review aims to present the latest evidence on RSV and the available vaccines. Of the five vaccines evaluated, three have demonstrated significant efficacy in individuals over 60 years of age. Based on the current evidence, it is recommended that individuals over 75 be offered RSV vaccination, with priority given to those with chronic heart or lung conditions, frailty, or who reside in long-term care facilities.</div></div>","PeriodicalId":39958,"journal":{"name":"Revista Espanola de Geriatria y Gerontologia","volume":"60 2","pages":"Article 101630"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Update on vaccines against respiratory syncytial virus (RSV): A narrative review\",\"authors\":\"José Gutierrez-Rodriguez , Jaime Rodríguez-Salazar , Francisco José Tarazona-Santabalbina\",\"doi\":\"10.1016/j.regg.2025.101630\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Respiratory syncytial virus (RSV) infections pose a significant challenge to healthcare systems due to their impact on older adults, particularly those who are frail. Implementing an appropriate vaccination policy for these patients could help reduce healthcare resource utilization and costs while enhancing the quality of life for elderly individuals and their families. This narrative review aims to present the latest evidence on RSV and the available vaccines. Of the five vaccines evaluated, three have demonstrated significant efficacy in individuals over 60 years of age. Based on the current evidence, it is recommended that individuals over 75 be offered RSV vaccination, with priority given to those with chronic heart or lung conditions, frailty, or who reside in long-term care facilities.</div></div>\",\"PeriodicalId\":39958,\"journal\":{\"name\":\"Revista Espanola de Geriatria y Gerontologia\",\"volume\":\"60 2\",\"pages\":\"Article 101630\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Espanola de Geriatria y Gerontologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0211139X25000101\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola de Geriatria y Gerontologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0211139X25000101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

呼吸道合胞病毒（RSV）感染对老年人，特别是体弱多病者的影响，对卫生保健系统构成重大挑战。对这些患者实施适当的疫苗接种政策可以帮助减少医疗资源的利用和成本，同时提高老年人及其家庭的生活质量。本综述旨在介绍关于呼吸道合胞病毒和现有疫苗的最新证据。在评估的五种疫苗中，有三种已证明对60岁以上的人有显著效力。根据目前的证据，建议为75岁以上的个体提供RSV疫苗接种，优先考虑患有慢性心肺疾病、虚弱或居住在长期护理机构的人。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Update on vaccines against respiratory syncytial virus (RSV): A narrative review

Respiratory syncytial virus (RSV) infections pose a significant challenge to healthcare systems due to their impact on older adults, particularly those who are frail. Implementing an appropriate vaccination policy for these patients could help reduce healthcare resource utilization and costs while enhancing the quality of life for elderly individuals and their families. This narrative review aims to present the latest evidence on RSV and the available vaccines. Of the five vaccines evaluated, three have demonstrated significant efficacy in individuals over 60 years of age. Based on the current evidence, it is recommended that individuals over 75 be offered RSV vaccination, with priority given to those with chronic heart or lung conditions, frailty, or who reside in long-term care facilities.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista Espanola de Geriatria y Gerontologia Medicine-Medicine (miscellaneous)

CiteScore

1.90

自引率

0.00%

发文量

审稿时长

85 days

期刊介绍： Una revista de gran prestigio por sus artículos originales de investigación y revisiones. Permite cubrir todas las áreas de la medicina pero siempre desde la atención al paciente anciano, y está presente en los más reconocidos índices internacionales.